157 results on '"Chuang, Hubert H."'
Search Results
2. Bone Metastases
3. Small Bowel Malignant Tumors
4. Contributors
5. Imaging of Bone Metastases
6. Imaging of the Parathyroid Carcinoma
7. Deciphering Tumor Response: The Role of Fluoro-18-d-Glucose Uptake in Evaluating Targeted Therapies with Tyrosine Kinase Inhibitors.
8. Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
9. Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma: A Report of 11 Cases Correlating Clinicopathologic and Radiologic Findings
10. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma
11. FDG PET/CT in Diagnosing COVID-19 Infection in a Cancer Patient With Exposure History But Minimal Symptoms
12. Correlation of fluorine 18-labeled sodium fluoride uptake and arterial calcification on whole-body PET/CT in cancer patients
13. Single-Institution Experience in the Treatment of Primary Mediastinal B Cell Lymphoma Treated With Immunochemotherapy in the Setting of Response Assessment by 18Fluorodeoxyglucose Positron Emission Tomography
14. Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment
15. Chapter 34 - Bone Metastases
16. Chapter 17 - Small Bowel Malignant Tumors
17. Chapter 14 - Pancreatic Neuroendocrine Tumors
18. Positron Emission Tomography for Assessing Local Failure After Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer
19. Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma
20. Impact of 18F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients
21. The value of 18F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors
22. FDG PET for the Detection of Bone Metastases: Sensitivity, Specificity and Comparison with Other Imaging Modalities
23. A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
24. Bone Metastases: Mechanisms of the Metastatic Process, Imaging and Therapy
25. Programmed Cell Death-One Inhibition Therapy in Classical Hodgkin Lymphoma
26. A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
27. Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma
28. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: New and future perspectives for parathyroid carcinoma
29. “Detecting the Undetectable”
30. Chimeric antigen receptor T‐cell therapy’s role in antiphospholipid syndrome: a case report
31. Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome
32. Nonstochastic Coexpression of Activation Receptors on Murine Natural Killer Cells
33. False-Positive Positron Emission Tomography After Combined-Modality Induction Therapy in a Patient With Newly Diagnosed Early-Stage Bulky Classic Hodgkin Lymphoma
34. The Clinical Impact of [68Ga]‐DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone – Secreting Tumours
35. American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism
36. New and future perspectives for parathyroid carcinoma.
37. Chimeric antigen receptor T‐cell therapy's role in antiphospholipid syndrome: a case report.
38. Positron emission tomography–computed tomography predictors of progression after DA-R-EPOCH for PMBCL
39. Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy
40. PET/CT of Osteosarcoma and Ewing Sarcoma
41. The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma
42. 18F-FDG PET/CT as an Indicator of Survival in Ewing Sarcoma of Bone
43. Chemotherapy-Free Induction with Ibrutinib-Rituximab Followed By Shortened Cycles of Chemo-Immunotherapy Consolidation in Young, Newly Diagnosed Mantle Cell Lymphoma Patients: A Phase II Clinical Trial
44. Lenalidomide and Obinutuzumab with CHOP for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Phase I Results
45. Fat-Containing Hypermetabolic Masses on FDG PET/CT: A Spectrum of Benign and Malignant Conditions
46. The Clinical Impact of [68Ga]‐DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone – Secreting Tumours.
47. Gene Expression Profiling for Molecular Features of Response in a Phase I Trial of Alisertib Plus Romidepsin for Relapsed/Refractory Aggressive B- and T-Cell Lymphomas
48. Abdominal Manifestations of Neuroendocrine Tumors
49. Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives.
50. Malignancy of unknown origin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.